ArticleHuman vaccines & immunotherapeutics2026
Health care providers' perspectives on county-level barriers and facilitators to HPV vaccination: A socio-ecological approach (2022-2023).
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Indiana, HPV vaccine series completion is 59.6%. Using a socio-ecological model (SEM) approach, this study investigates county health department providers' perspectives on improving vaccine initiation and completion among adolescents in Indiana. We conducted semi-structured interviews to explore health department providers' opinions on barriers and facilitators of HPV vaccine series initiation and completion amongst parents of adolescents. Thematic analysis was then conducted on the transcribed interviews. Interviews were conducted with 24 county health department providers across Indiana with 54.2% (n = 13) holding a Vaccine Coordinator position. Perceived barriers to initiation at the individual level included the parents' lack of education regarding the HPV vaccine and the importance of prevention. Interpersonally, misinformation and busy schedules for both the parents and adolescents hindered initiation and completion. Further, the presentation of the vaccine by the clinic could affect initiation and completion rates (both positively and negatively). Organizationally, having reminder systems regarding follow-up appointments was a facilitator to completion. Community-level barriers included a lack of providers, transportation, and language issues, but flexible scheduling options were a facilitator. Policy barriers included HPV not being a school-required vaccine. Participants provided valuable insight into perceptions of the HPV vaccine and the barriers and facilitators to HPV vaccine series initiation and completion in Indiana. Barriers to series completion included lack of information and conflicting schedules. Facilitators of series completion included reminder systems and flexible vaccination scheduling options. Interventions that include these facilitators can be developed to improve completion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.